Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Asthma and COVID-19: a systematic review

Full text
Author(s):
Mendes, Natalia F. [1, 2] ; Jara, Carlos P. [1, 2] ; Mansour, Eli [3] ; Araujo, Eliana P. [1, 2] ; Velloso, Licio A. [2, 3]
Total Authors: 5
Affiliation:
[1] Univ Estadual Campinas, Sch Nursing, Campinas - Brazil
[2] Univ Estadual Campinas, Obes & Comorbid Res Ctr, Lab Cell Signaling, Inst Biol, Rua Carl Lineaus S-N, BR-13083864 Campinas, SP - Brazil
[3] Univ Estadual Campinas, Dept Internal Med, Clin Immunol & Allergy, Campinas - Brazil
Total Affiliations: 3
Document type: Review article
Source: ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY; v. 17, n. 1 JAN 6 2021.
Web of Science Citations: 0
Abstract

BackgroundSevere coronavirus disease-19 (COVID-19) presents with progressive dyspnea, which results from acute lung inflammatory edema leading to hypoxia. As with other infectious diseases that affect the respiratory tract, asthma has been cited as a potential risk factor for severe COVID-19. However, conflicting results have been published over the last few months and the putative association between these two diseases is still unproven.MethodsHere, we systematically reviewed all reports on COVID-19 published since its emergence in December 2019 to June 30, 2020, looking into the description of asthma as a premorbid condition, which could indicate its potential involvement in disease progression.ResultsWe found 372 articles describing the underlying diseases of 161,271 patients diagnosed with COVID-19. Asthma was reported as a premorbid condition in only 2623 patients accounting for 1.6% of all patients.ConclusionsAs the global prevalence of asthma is 4.4%, we conclude that either asthma is not a premorbid condition that contributes to the development of COVID-19 or clinicians and researchers are not accurately describing the premorbidities in COVID-19 patients. (AU)

FAPESP's process: 13/07607-8 - OCRC - Obesity and Comorbidities Research Center
Grantee:Licio Augusto Velloso
Support type: Research Grants - Research, Innovation and Dissemination Centers - RIDC
FAPESP's process: 16/17810-3 - Evaluation of TGF-b1 function in the hypothalamus of animals with obesity and diabetes induced by high-fat diet
Grantee:Natália Ferreira Mendes
Support type: Scholarships in Brazil - Doctorate